Cargando…
In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer
BACKGROUND: Management of men with advanced prostate cancer has evolved to include urologists, made possible by oral targeted agents (eg, abiraterone or enzalutamide) that can be dispensed directly to patients in the office. We sought to investigate whether this increasingly common model improves ac...
Autores principales: | Hill, Dawson, Kaufman, Samuel R, Oerline, Mary K, Faraj, Kassem, Caram, Megan E V, Shahinian, Vahakn B, Hollenbeck, Brent K, Maganty, Avinash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555918/ https://www.ncbi.nlm.nih.gov/pubmed/37643638 http://dx.doi.org/10.1093/jncics/pkad062 |
Ejemplares similares
-
Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer
por: Lai, Lillian Y, et al.
Publicado: (2022) -
Health care delivery system contributions to management of newly diagnosed prostate cancer
por: Krampe, Noah, et al.
Publicado: (2023) -
Reimbursement and use of intensity-modulated radiation therapy for prostate cancer
por: Shahinian, Vahakn B., et al.
Publicado: (2017) -
Differential adoption of castration‐resistant prostate cancer treatment across facilities in a national healthcare system
por: Caram, Megan E. V., et al.
Publicado: (2023) -
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)
por: Skolarus, Ted A., et al.
Publicado: (2018)